Clinical Trial: Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Sponsor and Collaborators
Cancer and Leukemia Group B
National Cancer Institute (NCI)
Study Chair: Ghassan Abou-Alfa, MD Memorial Sloan-Kettering Cancer Center
Next post in Liver Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.